Steven Bernstein1, Anna North1, Jason Schwartz1, Linda M Niccolai1. 1. Steven Bernstein is with the Department of Emergency Medicine, Yale Cancer Center, New Haven, CT, and the Robert Wood Johnson Clinical Scholars Program, Yale School of Medicine, New Haven. Linda M. Niccolai and Anna North are with the Department of Epidemiology of Microbial Diseases, Yale School of Public Health and Yale Cancer Center. Jason Schwartz is with the Department of Health Policy and Management, Yale School of Public Health, New Haven.
Abstract
OBJECTIVES: To examine state-level associations between voting patterns and adolescent coverage for at least 1 dose of human papillomavirus (HPV), tetanus-containing (Tdap), and meningococcal (MCV4) vaccination. METHODS: We classified states as "blue" (Democratic affiliation) or "red" (Republican affiliation) based on the Presidential election results in 2012. We used multivariable models to adjust for potential confounding by sociodemographic and health care access characteristics and vaccination policies. For HPV, separate models were fitted for boys and girls. RESULTS: Adolescent vaccination coverage was significantly higher in blue states than red states for each vaccine (P < .05). The adjusted percent differences between blue and red states were 10.2% for HPV among girls, 24.9% for HPV among boys, 6.2% for tetanus-containing vaccine, and 14.1% for MCV4. CONCLUSIONS: State-level voting patterns are independently and significantly associated with coverage for routinely recommended adolescent vaccines. These differences may reflect population-level differences in cultural norms and social values. PUBLIC HEALTH IMPLICATIONS: Strategies to increase coverage at the individual, community, or structural level should consider local political settings that may facilitate or hinder effectiveness.
OBJECTIVES: To examine state-level associations between voting patterns and adolescent coverage for at least 1 dose of human papillomavirus (HPV), tetanus-containing (Tdap), and meningococcal (MCV4) vaccination. METHODS: We classified states as "blue" (Democratic affiliation) or "red" (Republican affiliation) based on the Presidential election results in 2012. We used multivariable models to adjust for potential confounding by sociodemographic and health care access characteristics and vaccination policies. For HPV, separate models were fitted for boys and girls. RESULTS: Adolescent vaccination coverage was significantly higher in blue states than red states for each vaccine (P < .05). The adjusted percent differences between blue and red states were 10.2% for HPV among girls, 24.9% for HPV among boys, 6.2% for tetanus-containing vaccine, and 14.1% for MCV4. CONCLUSIONS: State-level voting patterns are independently and significantly associated with coverage for routinely recommended adolescent vaccines. These differences may reflect population-level differences in cultural norms and social values. PUBLIC HEALTH IMPLICATIONS: Strategies to increase coverage at the individual, community, or structural level should consider local political settings that may facilitate or hinder effectiveness.
Authors: Laurie D Elam-Evans; David Yankey; Jenny Jeyarajah; James A Singleton; Robinette C Curtis; Jessica MacNeil; Susan Hariri Journal: MMWR Morb Mortal Wkly Rep Date: 2014-07-25 Impact factor: 17.586
Authors: Mallory K Ellingson; Robert A Bednarczyk; Sean T O'Leary; Jason L Schwartz; Eugene D Shapiro; Linda M Niccolai Journal: J Behav Med Date: 2022-02-22
Authors: Elizabeth K Do; Brianna Rossi; Carrie A Miller; Albert J Ksinan; David C Wheeler; Askar Chukmaitov; John W Cyrus; Bernard F Fuemmeler Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-10-02 Impact factor: 4.090
Authors: Maurane Riesen; Garyfallos Konstantinoudis; Ben D Spycher; Christian L Althaus; Phung Lang; Nicola Low; Christoph Hatz; Mirjam Maeusezahl; Anne Spaar; Marc Bühlmann Journal: BMJ Open Date: 2018-05-17 Impact factor: 2.692
Authors: Danielle F Haley; Andrew Edmonds; Victor J Schoenbach; Catalina Ramirez; DeMarc A Hickson; Gina M Wingood; Hector Bolivar; Elizabeth Golub; Adaora A Adimora Journal: Ann Epidemiol Date: 2018-10-29 Impact factor: 3.797